A comprehensive literature-based equation to compare cost-effectiveness of a flexible ureteroscopy program with single-use versus reusable devices

Carregando...
Imagem de Miniatura
Citações na Scopus
33
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
BRAZILIAN SOC UROL
Citação
INTERNATIONAL BRAZ J UROL, v.45, n.4, p.658-670, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Purpose: to critically review all literature concerning the cost-effectiveness of flexible ureteroscopy comparing single-use with reusable scopes. Materials and Methods: A systematic online literature review was performed in PubMed, Embase and Google Scholar databases. All factors potentially affecting surgical costs or clinical outcomes were considered. Prospective assessments, case control and case series studies were included. Results: 741 studies were found. Of those, 18 were duplicated and 77 were not related to urology procedures. Of the remaining 646 studies, 59 were considered of relevance and selected for further analysis. Stone free and complication rates were similar between single-use and reusable scopes. Operative time was in average 20% shorter with digital scopes, single-use or not. Reusable digital scopes seem to last longer than optic ones, though scope longevity is very variable worldwide. New scopes usually last four times more than refurbished ones and single-use ureterorenoscopes have good resilience throughout long cases. Longer scope longevity is achieved with Cidex and if a dedicated nurse takes care of the sterilization process. The main surgical factors that negatively impact device longevity are lower pole pathologies, large stone burden and non-use of a ureteral access sheath. We have built a comprehensive financial cost-effective decision model to flexible ureteroscope acquisition. Conclusions: The cost-effectiveness of a flexible ureteroscopy program is dependent of several aspects. We have developed a equation to allow a literature-based and adaptable decision model to every interested stakeholder. Disposable devices are already a reality and will progressively become the standard as manufacturing price falls.
Palavras-chave
Cost-Benefit Analysis, Ureteroscopy, Kidney Calculi
Referências
  1. Abraham JBA, 2007, J ENDOUROL, V21, P985, DOI 10.1089/end.2007.0181
  2. Afane JS, 2000, J UROLOGY, V164, P1164, DOI 10.1016/S0022-5347(05)67133-9
  3. Alezra E, 2016, PROG UROL, V26, P65, DOI 10.1016/j.purol.2015.09.008
  4. Assimos D, 2016, J UROLOGY, V196, P1161, DOI 10.1016/j.juro.2016.05.091
  5. Assimos D, 2016, J UROLOGY, V196, P1153, DOI 10.1016/j.juro.2016.05.090
  6. Auge BK, 2004, J ENDOUROL, V18, P33, DOI 10.1089/089277904322836631
  7. Bader MJ, 2010, J ENDOUROL, V24, P1061, DOI 10.1089/end.2010.0077
  8. Bagley D H, 1987, Surg Endosc, V1, P119, DOI 10.1007/BF00312699
  9. Bansal H, 2011, J ENDOUROL, V25, P317, DOI 10.1089/end.2009.0584
  10. Berquet G, 2014, WORLD J UROL, V32, P229, DOI 10.1007/s00345-013-1181-5
  11. Binbay M, 2010, J ENDOUROL, V24, P1929, DOI 10.1089/end.2010.0211
  12. Boylu U, 2009, J UROLOGY, V182, P2347, DOI 10.1016/j.juro.2009.07.031
  13. Carey RI, 2006, J UROLOGY, V176, P607, DOI 10.1016/j.juro.2006.03.059
  14. Carey RI, 2014, UROLOGY, V84, P42, DOI 10.1016/j.urology.2014.01.022
  15. Collins JW, 2004, BJU INT, V93, P1023, DOI 10.1111/j.1464-410X.2003.04774.x
  16. Dale J, 2017, J ENDOUROL
  17. Davis NF, 2018, J ENDOUROL, V32, P214, DOI 10.1089/end.2018.0001
  18. Defidio L, 2012, J ENDOUROL, V26, P1329, DOI 10.1089/end.2012.0178
  19. Ding J, 2015, UROLOGY, V86, P224, DOI 10.1016/j.urology.2015.04.018
  20. Doizi S, 2017, WORLD J UROL, V35, P809, DOI 10.1007/s00345-016-1936-x
  21. Emiliani E, 2017, CURR OPIN UROL, V27, P176, DOI 10.1097/MOU.0000000000000371
  22. Forbes CM, 2018, LASER SURG MED, V50, P798, DOI 10.1002/lsm.22822
  23. Ghodoussipour S, 2017, J UROLOGY, V197, pE686, DOI 10.1016/j.juro.2017.02.1596
  24. Gu SP, 2013, EXP THER MED, V6, P591, DOI 10.3892/etm.2013.1184
  25. Gurbuz C, 2014, UROLITHIASIS, V42, P155, DOI 10.1007/s00240-013-0628-x
  26. Hennessey DB, 2018, BJU INT, V121, P55, DOI 10.1111/bju.14235
  27. Isaacson D, 2017, J ENDOUROL, V31, P1026, DOI 10.1089/end.2017.0463
  28. Jacquemet B, 2014, J ENDOUROL, V28, P1183, DOI 10.1089/end.2014.0286
  29. Jessen JP, 2014, J ENDOUROL, V28, P146, DOI 10.1089/end.2013.0401
  30. Johnson MT, 2013, J ENDOUROL, V27, P71, DOI 10.1089/end.2012.0323
  31. Karaolides T, 2013, UROLOGY, V81, P717, DOI 10.1016/j.urology.2013.01.016
  32. Knudsen B, 2010, UROLOGY, V75, P534, DOI 10.1016/j.urology.2009.06.093
  33. Kourambas J, 2001, J UROLOGY, V165, P789, DOI 10.1016/S0022-5347(05)66527-5
  34. Kourambas J, 2000, UROLOGY, V56, P935, DOI 10.1016/S0090-4295(00)00821-9
  35. Kramolowsky E, 2016, J ENDOUROL, V30, P254, DOI 10.1089/end.2015.0642
  36. Landman J, 2003, UROLOGY, V62, P218, DOI 10.1016/S0090-4295(03)00376-5
  37. Legemate JD, 2019, J UROLOGY, V201, P1144, DOI 10.1097/JU.0000000000000108
  38. Mager R, 2018, UROLITHIASIS, V46, P587, DOI 10.1007/s00240-018-1042-1
  39. Marchini GS, 2018, J ENDOUROL, V32, P184, DOI 10.1089/end.2017.0785
  40. Martin CJ, 2017, J UROLOGY, V197, P730, DOI 10.1016/j.juro.2016.09.085
  41. Martin F, 2014, J ENDOUROL, V28, P141, DOI 10.1089/end.2013.0515
  42. McDougall EM, 2001, J ENDOUROL, V15, P615, DOI 10.1089/089277901750426409
  43. Moher David, 2009, PLoS Med, V6, pe1000097, DOI 10.1371/journal.pmed.1000097
  44. Monga M, 2006, J UROLOGY, V176, P137, DOI 10.1016/S0022-5347(06)00575-1
  45. Multescu R, 2014, UROLOGY, V84, P32, DOI 10.1016/j.urology.2014.01.021
  46. Ofstead CL, 2017, AM J INFECT CONTROL, V45, P888, DOI 10.1016/j.ajic.2017.03.016
  47. Ozimek T, 2017, J ENDOUROL, V31, P1226, DOI 10.1089/end.2017.0427
  48. Perlmutter AE, 2008, UROLOGY, V71, P214, DOI 10.1016/j.urology.2007.09.023
  49. Pietrow PK, 2002, UROLOGY, V60, P784, DOI 10.1016/S0090-4295(02)01948-9
  50. Proietti S, 2016, J ENDOUROL, V30, P655, DOI 10.1089/end.2016.0051
  51. Resorlu B, 2012, UROLOGY, V80, P512, DOI 10.1016/j.urology.2012.02.072
  52. Roupret M, 2015, EUR UROL, V68, P868, DOI 10.1016/j.eururo.2015.06.044
  53. Schuster TG, 2002, J UROLOGY, V168, P43, DOI 10.1016/S0022-5347(05)64828-8
  54. Semins MJ, 2009, J ENDOUROL, V23, P903, DOI 10.1089/end.2008.0489
  55. Shah K, 2015, UROLOGY, V85, P1267, DOI 10.1016/j.urology.2014.12.012
  56. Siu JJY, 2016, INQUIRY-J HEALTH CAR, V53, DOI 10.1177/0046958016669015
  57. Somani BK, 2013, UROLOGY, V82, P1017, DOI 10.1016/j.urology.2013.07.017
  58. Somani BK, 2011, UROLOGY, V78, P528, DOI 10.1016/j.urology.2010.12.073
  59. Stern JM, 2007, J ENDOUROL, V21, P119, DOI 10.1089/end.2007.9997
  60. Taguchi K, 2018, J ENDOUROL, V32, P267, DOI 10.1089/end.2017.0523
  61. Tom WR, 2017, J ENDOUROL, V31, P1301, DOI 10.1089/end.2017.0447
  62. Tosoian JJ, 2015, J ENDOUROL, V29, P406, DOI 10.1089/end.2014.0435
  63. Traxer O, 2006, UROLOGY, V68, P276, DOI 10.1016/j.urology.2006.02.043
  64. Turk C, 2016, EUR UROL, V69, P475, DOI 10.1016/j.eururo.2015.07.041
  65. Usawachintachit M, 2017, J ENDOUROL, V31, P468, DOI 10.1089/end.2017.0027
  66. User HM, 2004, J ENDOUROL, V18, P735
  67. White Mark D., 1998, Journal of Endourology, V12, pS182
  68. Wiseman O, 2016, J UROLOGY, V195, pE682, DOI 10.1016/j.juro.2016.02.458